Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course.
Conclusion: Monocytopenia, especially anemia, was the most common type of cytopenia. The cytopenia was predominantly grade 2, developed in majority of the patients within 6 months after imatinib initiation, and had resolved by 24-36 months after imatinib initiation.
PMID: 32454829 [PubMed]
Source: Advances in Hematology - Category: Hematology Tags: Adv Hematol Source Type: research
More News: Anemia | Chronic Leukemia | Chronic Myeloid Leukaemia | Gleevec | Hematology | Kenya Health | Leukemia | Pancytopenia | Study | Thrombocytopenia | Toxicology